BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 21084400)

  • 1. Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors.
    Bonnet S; Gaujoux S; Launay P; Baudry C; Chokri I; Ragazzon B; Libé R; René-Corail F; Audebourg A; Vacher-Lavenu MC; Groussin L; Bertagna X; Dousset B; Bertherat J; Tissier F
    J Clin Endocrinol Metab; 2011 Feb; 96(2):E419-26. PubMed ID: 21084400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
    Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
    Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
    Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
    Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of genetic alterations of AXIN2 gene in adrenocortical tumors.
    Chapman A; Durand J; Ouadi L; Bourdeau I
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1477-81. PubMed ID: 21733995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt/beta-catenin pathway deregulation in childhood adrenocortical tumors.
    Leal LF; Mermejo LM; Ramalho LZ; Martinelli CE; Yunes JA; Seidinger AL; Mastellaro MJ; Cardinalli IA; Brandalise SR; Moreira AC; Tone LG; Scrideli CA; Castro M; Antonini SR
    J Clin Endocrinol Metab; 2011 Oct; 96(10):3106-14. PubMed ID: 21849527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.
    Thiel A; Reis AC; Haase M; Goh G; Schott M; Willenberg HS; Scholl UI
    Eur J Endocrinol; 2015 Jun; 172(6):677-85. PubMed ID: 25750087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas.
    Tadjine M; Lampron A; Ouadi L; Bourdeau I
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):264-70. PubMed ID: 17854394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Landscape of Sporadic Unilateral Adrenocortical Adenomas Without PRKACA p.Leu206Arg Mutation.
    Ronchi CL; Di Dalmazi G; Faillot S; Sbiera S; Assié G; Weigand I; Calebiro D; Schwarzmayr T; Appenzeller S; Rubin B; Waldmann J; Scaroni C; Bartsch DK; Mantero F; Mannelli M; Kastelan D; Chiodini I; Bertherat J; Reincke M; Strom TM; Fassnacht M; Beuschlein F;
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3526-38. PubMed ID: 27389594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of stabilizing mutations of beta-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas.
    Costa-Guda J; Arnold A
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1564-6. PubMed ID: 17284619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.
    Gaujoux S; Pinson S; Gimenez-Roqueplo AP; Amar L; Ragazzon B; Launay P; Meatchi T; Libé R; Bertagna X; Audebourg A; Zucman-Rossi J; Tissier F; Bertherat J
    Clin Cancer Res; 2010 Nov; 16(21):5133-41. PubMed ID: 20978149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas.
    Huang SC; Ng KF; Yeh TS; Chang HC; Su CY; Chen TC
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S438-46. PubMed ID: 21769465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration in the Wnt/β-catenin signaling pathway in gastric neoplasias of fundic gland (chief cell predominant) type.
    Hidaka Y; Mitomi H; Saito T; Takahashi M; Lee SY; Matsumoto K; Yao T; Watanabe S
    Hum Pathol; 2013 Nov; 44(11):2438-48. PubMed ID: 24011952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD).
    Tadjine M; Lampron A; Ouadi L; Horvath A; Stratakis CA; Bourdeau I
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):367-73. PubMed ID: 18419788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activating mutations in CTNNB1 in aldosterone producing adenomas.
    Åkerström T; Maharjan R; Sven Willenberg H; Cupisti K; Ip J; Moser A; Stålberg P; Robinson B; Alexander Iwen K; Dralle H; Walz MK; Lehnert H; Sidhu S; Gomez-Sanchez C; Hellman P; Björklund P
    Sci Rep; 2016 Jan; 6():19546. PubMed ID: 26815163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target genes of the WNT/beta-catenin pathway in Wilms tumors.
    Zirn B; Samans B; Wittmann S; Pietsch T; Leuschner I; Graf N; Gessler M
    Genes Chromosomes Cancer; 2006 Jun; 45(6):565-74. PubMed ID: 16575872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas.
    Cetani F; Pardi E; Banti C; Collecchi P; Viacava P; Borsari S; Fanelli G; Naccarato AG; Saponaro F; Berti P; Miccoli P; Pinchera A; Marcocci C
    Endocr Relat Cancer; 2010 Mar; 17(1):1-6. PubMed ID: 19755524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of a stabilizing mutation of β-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas.
    Starker LF; Fonseca AL; Akerström G; Björklund P; Westin G; Carling T
    Endocrine; 2012 Dec; 42(3):612-5. PubMed ID: 22576020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
    Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
    Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear β-catenin expression in basal cell adenomas of salivary gland.
    Kawahara A; Harada H; Abe H; Yamaguchi T; Taira T; Nakashima K; Mihashi H; Akiba J; Kage M
    J Oral Pathol Med; 2011 Jul; 40(6):460-6. PubMed ID: 21323741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.